308 results
8-K
EX-10.3
EBS
Emergent BioSolutions Inc.
3 Sep 24
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
7:47am
independent investigation made by such Subscriber and/or any professional advisor(s) of such Subscriber. Each Subscriber is aware that ownership
8-K
EX-10.2
EBS
Emergent BioSolutions Inc.
3 Sep 24
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
7:47am
Transaction, as determined by the Board of Directors of the Company, in good faith, based upon the advice of an independent bank of national standing selected … a volume weighted average price method by an independent nationally recognized investment bank or other qualified financial institution selected
8-K
EX-10.1
EBS
Emergent BioSolutions Inc.
3 Sep 24
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
7:47am
; Anti-Money Laundering Laws
SECTION 12.19
Independent Effect of Covenants
SECTION 12.20
No Advisory or Fiduciary Responsibility
SECTION 12.21 … and Federal Acquisition Regulation 52.203-3; (e) the Truth in Negotiations Act, 41 U.S.C. §§ 3501-3509; (f) the independent pricing requirements
S-8
EX-23.1
EBS
Emergent BioSolutions Inc.
6 Aug 24
Registration of securities for employees
4:34pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
dp0w8 tc9m
6 Aug 24
Registration of securities for employees
4:34pm
8-K
EX-10.1
fkf91i6sdi0co
29 May 24
Departure of Directors or Certain Officers
7:34am
8-K
EX-99.1
tcktalydlf2klo
29 May 24
Departure of Directors or Certain Officers
7:34am
8-K
bax vy9dba2mxbl8ta
29 May 24
Departure of Directors or Certain Officers
7:34am
8-K
EX-10.1
hv3dyllt
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
DEFA14A
9857fk9ecy
11 Apr 24
Additional proxy soliciting materials
5:27pm
8-K
EX-10.1
8rsjb9ss87 jm
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
8-K
EX-10.1
fd6 pwzftklb
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
S-8 POS
1b6dznl7r3jiu
12 Dec 23
Registration of securities for employees (post-effective amendment)
7:05pm
S-8
vddpnl5edoo51q
11 Dec 23
Registration of securities for employees
5:22pm
S-8
EX-23.1
5qprtyv3ipi7tbdp
11 Dec 23
Registration of securities for employees
5:22pm